Endologix Reveals Positive Clinical Data From Nellix EVAS FORWARD-IDE Study
May 26, 2016 at 12:12 PM EDT
Endologix, Inc. (NASDAQ: ELGX) revealed positive clinical data from the Nellix investigational device exemption (IDE) clinical study, ...